Shanghai Medical University, China, 1997
Ph.D., University of Florida, Pharmacology, 2002
University of Florida, Shands Hospital, Gainesville, FL
Research and Clinical Interests
He has a strong interest in translational research in Central Nervous System and Genitourinary malignancies. His research focuses on incorporating novel molecular targeting agents into conventional anti-cancer therapy, especially in combination with radiation. His current research includes a variety of different new agents, such as anti-angiogenic agents, vascular disrupting agents, signal transduction pathway inhibitors, and immune modulators. These agents will be evaluated in clinical trials for the treatment of a broad spectrum of CNS and GU malignancies, with special focus on glioblastoma and prostate cancer.